Investor Relations Home
Download Documentation 2016 Guidance Worksheet
Download Documentation ALN-PCSsc Phase 1 Clinical Results Presentation
Download Documentation Update on ABP-700
Download Documentation ALN-PCSsc Phase 1 Clinical Results Presentation
Download Documentation ABP-700 & MDCO-216 Conference Call Presentation
Corporate Profile
The Medicines Company provides medical solutions to improve health outcomes for patients in acute and intensive care hospitals worldwide. These solutions comprise medicines and knowledge that directly impact the survival and well-being of critically ill patients.
Stock Quote
MDCO (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$29.83
Change (%) Stock is Down 1.79 (5.66%)
Volume2,198,786
Data as of 02/22/18 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent News
DateTitle 
02/21/18The Medicines Company Reports Fourth-Quarter and Full-Year 2017 Business and Financial Results
PARSIPPANY, N.J.--(BUSINESS WIRE)--Feb. 21, 2018-- The Medicines Company (NASDAQ:MDCO) today reported its financial results for the fourth quarter and full year ended December 31, 2017. “We have successfully executed our strategic action plan for 2017 by divesting our non-core assets, restructuring our business to focus on inclisiran, and initiating the inclisiran Phase 3 ORION program – recently completing target enrollment ahead of schedule in ... 
Printer Friendly Version
02/20/18The Medicines Company Reaches Enrollment Target for ORION-9 Ahead of Schedule
ORION-9, a Phase III confirmatory clinical trial in heterozygous familial hypercholesterolemia patients randomized more than 400 patients in 10 weeks – 14 weeks ahead of schedule PARSIPPANY, N.J.--(BUSINESS WIRE)--Feb. 20, 2018-- The Medicines Company (NASDAQ: MDCO) today announced that the target of 400 patients randomized in the ORION-9 trial has been exceeded in 10 weeks – considerably ahead of its anticipated recruitment goal of 24 ... 
Printer Friendly Version
02/14/18The Medicines Company to Host Conference Call and Webcast Discussing Fourth-Quarter and Full-Year 2017 Financial Results
PARSIPPANY, N.J.--(BUSINESS WIRE)--Feb. 14, 2018-- The Medicines Company (NASDAQ: MDCO) will host a conference call and webcast on Wednesday, February 21, 2018, at 8:30 a.m., Eastern Time, to discuss fourth-quarter and full-year 2017 financial results and operational developments. The conference call may be accessed by telephone as follows:   U.S./Canada: ... 
Printer Friendly Version
02/08/18The Medicines Company to Participate in the Leerink Partners 7th Annual Global Healthcare Conference
PARSIPPANY, N.J.--(BUSINESS WIRE)--Feb. 8, 2018-- The Medicines Company (NASDAQ:MDCO) today announced that it will participate in the Leerink Partners 7th Annual Global Healthcare Conference on Wednesday, February 14, 2018, in New York City. Clive Meanwell, M.D., Ph.D., Chief Executive Officer, will participate in a fireside chat at 9:00 a.m., Eastern Time. A live audio webcast will be available in the “Investors-Events/Presentations” sect... 
Printer Friendly Version
Upcoming Events
There are currently no events scheduled.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.